After this the fly studies for IPAM were funded! So we have more lifespan data to look forward to.
Unsure mate. I’d say it would be at least 5%. There is no official standard amount this is all very new. I say just give it a go and get before/after photos!
Question for Rapamycin News community: We want the fly study to go as well as possible. We cannot do a dose response study. What ideas for the optimal dose do you have?
I’ve also contacted Burkhard for insight but I want more perspectives.
Congrats! How does it work: people just buy the token to fund the study? A % of the AUM goes to the funding? Do people get something in return or is it just a meme coin / gun way of donating?
People buy the token either to support the molecule, or to profit, or both. They might support the dev behind the token, which is a big part of what is driving Rapamycin Longevity Lab’s tokens.
A % of the trading fees goes towards funding the studies. It’s probably the best use case for a crypto I’ve seen outside of directly using it as a currency.
Once the market cap his 303 SOL, 3 SOL is used to fund the experiment: where do these 3 SOL come from? For other experiments it’s just the trading fees that fund it? So it’s purely a meme coin?
Good eyes, @adssx! I think this is not valid data anymore because pump.science has switched labs who conduct the experiments. If I remember it correctly the experiments costs are as follows 500$ worms, 1500$ flies and 7000$ for mice but then there are additional costs when it comes to mice depending on what experiments that the dev team wants to do.
@AustraliaLongevity can you point out to pump.science that the page you refered to has not correct data around cost of the experiments?
Good point. I thought it didn’t look right. This is why I’ve always not been sure if experiments have been funded despite people saying they have been.
I ran out and stopped using it for the time being and I’m trying other things. I am experimenting with IPAM in a topical hair serum. Hard to say what that is doing tbh.
While I’m not as bullish on IPAM anymore I’m still excited to see the fly study. It’s funny how that worked out, we didn’t need to raise any money here to get that going.